1,384 Shares in Chemed Corporation $CHE Bought by Wilian Securities LLC

Posted by Brian Himes on May 22nd, 2026

Wilian Securities LLC acquired a new stake in Chemed Corporation (NYSE:CHE – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 1,384 shares of the company’s stock, valued at approximately $592,000.

A number of other institutional investors have also recently bought and sold shares of the business. Northwestern Mutual Wealth Management Co. grew its stake in Chemed by 2,444,879.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock valued at $2,374,667,000 after purchasing an additional 5,549,876 shares during the period. JPMorgan Chase & Co. grew its stake in Chemed by 122.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 499,968 shares of the company’s stock valued at $223,856,000 after purchasing an additional 275,423 shares during the period. William Blair Investment Management LLC grew its stake in Chemed by 13.6% in the 3rd quarter. William Blair Investment Management LLC now owns 385,124 shares of the company’s stock valued at $172,435,000 after purchasing an additional 46,038 shares during the period. Epoch Investment Partners Inc. grew its stake in Chemed by 29.4% in the 3rd quarter. Epoch Investment Partners Inc. now owns 307,275 shares of the company’s stock valued at $137,579,000 after purchasing an additional 69,878 shares during the period. Finally, TD Asset Management Inc grew its stake in Chemed by 23.1% in the 3rd quarter. TD Asset Management Inc now owns 301,831 shares of the company’s stock valued at $135,142,000 after purchasing an additional 56,546 shares during the period. Institutional investors own 95.85% of the company’s stock.

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the transaction, the chief executive officer owned 90,219 shares of the company’s stock, valued at $37,993,927.47. This represents a 2.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 3.33% of the stock is owned by corporate insiders.

Chemed Stock Down 0.0%

Shares of NYSE CHE opened at $441.58 on Friday. Chemed Corporation has a one year low of $365.20 and a one year high of $581.20. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. The business’s fifty day moving average price is $399.53 and its 200-day moving average price is $424.95. The stock has a market capitalization of $5.86 billion, a PE ratio of 24.06, a P/E/G ratio of 1.66 and a beta of 0.54.

Chemed (NYSE:CHE – Get Free Report) last issued its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, beating analysts’ consensus estimates of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. During the same quarter in the prior year, the firm earned $5.63 EPS. The business’s revenue for the quarter was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, equities research analysts anticipate that Chemed Corporation will post 22.3 EPS for the current year.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th will be given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Thursday, May 28th. Chemed’s dividend payout ratio is currently 13.08%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on CHE. Oppenheimer reduced their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research note on Friday, February 27th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Royal Bank Of Canada upped their price objective on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Finally, Wall Street Zen upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Two research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $501.50.

Get Our Latest Stock Report on CHE

Chemed Profile

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.